We developed an enzyme-linked immunosorbent assay (ELIsA) system for antibodies to the hepatitis C virus (HCV), using two new recombinant antigens (ci 1 and c7) derived from the HCV genome.
The performance of this The absorbance means were 0.05-1.89 for these control sera during 4 days of measurements, and the CVs ranged from 3.4% to 6.4% (Table 2) .
Materials and Methods

Materials
Interference.
We Figure  1 ). Bilirubin (up to 202 mg/L) and turbidity (with lipid up to 16.5 gIL) also showed no interference. 
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